0001666071-23-000139.txt : 20231003
0001666071-23-000139.hdr.sgml : 20231003
20231003182748
ACCESSION NUMBER: 0001666071-23-000139
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231001
FILED AS OF DATE: 20231003
DATE AS OF CHANGE: 20231003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lynton Nicholas Hollmeyer
CENTRAL INDEX KEY: 0001941467
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38386
FILM NUMBER: 231305854
MAIL ADDRESS:
STREET 1: C/O CARDLYTICS, INC.
STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardlytics, Inc.
CENTRAL INDEX KEY: 0001666071
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
IRS NUMBER: 263039436
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
BUSINESS PHONE: 888-798-5802
MAIL ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
4
1
wk-form4_1696372056.xml
FORM 4
X0508
4
2023-10-01
0
0001666071
Cardlytics, Inc.
CDLX
0001941467
Lynton Nicholas Hollmeyer
C/O CARDLYTICS, INC.
675 PONCE DE LEON AVENUE NE, SUITE 6000
ATLANTA
GA
30308
0
1
0
0
Chief Legal & Privacy Officer
0
Common Stock
2023-10-01
4
M
0
25000
A
54486
D
Common Stock
2023-10-01
4
M
0
415
A
54901
D
Common Stock
2023-10-01
4
M
0
582
A
55483
D
Common Stock
2023-10-01
4
M
0
1578
A
57061
D
Common Stock
2023-10-02
4
S
0
6900
13.55
D
50161
D
Common Stock
2023-10-02
4
S
0
3703
14.92
D
46458
D
Common Stock
2023-10-02
4
S
0
2101
15.70
D
44357
D
Common Stock
2023-10-02
4
S
0
47
16.35
D
44310
D
Restricted Stock Unit
2023-10-01
4
M
0
25000
0
D
Common Stock
25000
50000
D
Restricted Stock Unit
2023-10-01
4
M
0
415
0
D
Common Stock
415
0
D
Restricted Stock Unit
2023-10-01
4
M
0
582
0
D
Common Stock
582
5812
D
Restricted Stock Unit
2023-10-01
4
M
0
1578
0
D
Common Stock
1578
17358
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.
Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on October 1, 2023.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $13.21 to $14.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4) and (5) to this Form 4.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $14.27 to $15.265, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $15.275 to $16.23, inclusive.
This RSU award was originally for 100,000 shares. 25% of the RSUs award vested on each of July 1, 2023 and October 1, 2023. An additional 25% of the RSU award shall vest on each of January 1, 2024 and April 1, 2024, subject to the Reporting Person's continuous service with the Issuer through each applicable vesting date.
This RSU award was originally for 830 shares. Fifty percent (50%) of the shares under this award vested on October 1, 2022, and fifty percent (50%) of this award vested on October 1, 2023.
This RSU award was originally for 9,299 shares. Twenty-five percent (25%) of the shares under this award vested on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date.
This RSU award was originally for 38,222 shares. Twenty-five percent (25%) of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date.
/s/ Jason Minio, Attorney-in-Fact
2023-10-03